Muscular dystrophy refers to a group of inherited conditions in which faulty genes cause muscle fibres to weaken and waste away over time. Duchenne and Becker muscular dystrophy are the forms most often diagnosed in childhood, while limb-girdle, facioscapulohumeral and myotonic types may appear later. Because the cause is genetic, care worldwide centres on preserving strength and mobility for as long as possible through physiotherapy, orthotic support, steroid therapy where indicated, and close monitoring of heart and lung function. Families from across Pakistan — Karachi, Lahore, Peshawar, Quetta and beyond — frequently ask whether stem cell therapy adds anything to this picture. Stem Cell Cure India reviews each case individually and gives an honest opinion on whether an evaluation is worthwhile.
Coordinated muscular dystrophy care that brings together neurology, cardiology, respiratory medicine and physiotherapy under one roof is difficult to arrange in much of Pakistan, and genetic confirmation of the exact dystrophy subtype is not always available locally. Parents who have watched steady decline despite regular therapy often want a specialist assessment that combines confirmatory diagnostics with a candid view on whether regenerative options are worth considering in their child’s particular subtype and stage.
Dr. Tyagi leads regenerative medicine protocol design at Stem Cell Cure India, overseeing stem cell sourcing, lab processing, and treatment planning for patients being evaluated for muscular dystrophy and other neuromuscular conditions.
Dr. Singh brings over three decades of clinical experience in general medicine and surgery, and reviews the overall fitness of patients arriving from Pakistan before any treatment plan is finalised.
Mesenchymal Stem Cells (MSCs) are under investigation for anti-inflammatory and immunomodulatory properties, and for a possible supportive role in the muscle environment in some neuromuscular research settings. Families should be clear about what this does and does not mean: the underlying genetic defect causing muscular dystrophy is not corrected by stem cell therapy, muscle fibres already lost are not known to be rebuilt by it, and no available treatment currently halts the condition. Any evaluation here is offered strictly as an addition to — never a replacement for — physiotherapy, prescribed steroid or cardiac medication, and ongoing respiratory and cardiac surveillance.
Much depends on which dystrophy subtype is involved, the age at which symptoms began, and how much functional strength remains today. Before you make travel plans from Pakistan, our team looks at:
No. Muscular dystrophy is caused by a genetic defect, and stem cell therapy does not correct that defect or rebuild muscle already lost. It is discussed only as a possible addition to physiotherapy and standard medical management, never as a cure.
The subtype matters a great deal when assessing suitability, because age of onset, rate of progression and cardiac involvement differ between Duchenne, Becker, limb-girdle and other forms. Send the genetic report if you have one so the opinion you receive is based on the correct subtype.
Start with the genetic report, recent CPK levels, muscle biopsy findings if available, and the latest echocardiogram and pulmonary function results. A short note on current walking ability and ongoing physiotherapy also helps.
No. Physiotherapy, prescribed steroids and cardiac or respiratory medication should continue exactly as directed by your treating doctor. Nothing discussed here replaces that treatment.
Plan for roughly 7 to 10 days. The exact length depends on which investigations need repeating and what the assessment concludes.
Costs vary with subtype, severity and the plan proposed, so we quote individually rather than publishing a fixed price. Send your reports and our team will come back with a personalised estimate.
Source: These are real, verified Google reviews currently published on stemcellcure.in — pulled from our Google Business Profile (5.0★, 33+ reviews).
Send us your child’s reports and medical history, and our team will give you a straightforward opinion on whether an evaluation makes sense.
